TEVA insider filings

TEVA PHARMACEUTICAL INDUSTRIES LTD — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen TEVA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 15 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
MIGNONE ROBERTO — Director1—1 leg · 367,600 sh · $14,356,802—
Francis Richard D — President and CEO1—1 leg · 250,000 sh · $10,559,175—
Sabag Mark — See "Remarks"2—2 legs · 90,710 sh · $3,902,2744
Daniell Richard — EVP, Europe Commercial1—2 legs · 45,003 sh · $1,928,9444
Weiss Amir — Chief Accounting Officer2—5 legs · 26,734 sh · $1,099,3504
Bergwerk Dov — Interim Chief Legal Officer4—2 legs · 26,260 sh · $1,095,5677
Savage Brian — Interim Chief Legal Officer1—3 legs · 7,342 sh · $285,2152
Satchi-Fainaro Ronit — Director1—1 leg · 415 sh · $15,459—
BRAILER DAVID J — Director2——1

Recent insider filings — TEVA PHARMACEUTICAL INDUSTRIES LTD

FiledFormInsiderReported transactionsSource
2026-11-174Bergwerk Dov — Interim Chief Legal OfficerOption exercise (M): 8,370 · Option exercise (M): 8,370 (derivative) @ $0EDGAR
2026-11-124Daniell Richard — EVP, Europe CommercialOption exercise (M): 25,000 @ $34.70 · Sale (S): 25,000 @ $42.91 · Option exercise (M): 20,003 @ $34.70 · Sale (S): 20,003 @ $42.80 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 20,003 (derivative) @ $0EDGAR
2026-11-124Sabag Mark — See "Remarks"Option exercise (M): 44,710 @ $34.90 · Sale (S): 44,710 @ $44.14 · Option exercise (M): 44,710 (derivative) @ $0EDGAR
2026-11-124Francis Richard D — President and CEOSale (S): 250,000 @ $42.24EDGAR
2026-11-124Bergwerk Dov — Interim Chief Legal OfficerGrant/award (A): 9,433 (derivative) @ $0EDGAR
2026-11-124Weiss Amir — Chief Accounting OfficerOption exercise (M): 7,755 @ $34.70 · Sale (S): 662 @ $43.15 · Sale (S): 7,093 @ $43.03 · Sale (S): 9,534 @ $43.03 · Option exercise (M): 7,755 (derivative) @ $0EDGAR
2026-11-124BRAILER DAVID J — DirectorGrant/award (A): 3,326 (derivative) @ $0EDGAR
2026-11-123BRAILER DAVID J — DirectorHoldings only — no transactions reportedEDGAR
2026-11-064Sabag Mark — See "Remarks"Option exercise (M): 46,000 @ $34.90 · Sale (S): 46,000 @ $41.93 · Option exercise (M): 46,000 (derivative) @ $0EDGAR
2026-11-064Bergwerk Dov — Interim Cheif Legal OfficerOption exercise (M): 17,505 @ $34.70 · Sale (S): 17,505 @ $41.72 · Option exercise (M): 8,755 @ $28.98 · Sale (S): 8,755 @ $41.72 · Option exercise (M): 17,505 (derivative) @ $0 · Option exercise (M): 8,755 (derivative) @ $0EDGAR
2026-10-083Bergwerk Dov — Interim Cheif Legal OfficerHoldings only — no transactions reportedEDGAR
2026-09-224Savage Brian — Interim Chief Legal OfficerOption exercise (M): 4,503 @ $34.70 · Sale (S): 4,503 @ $38.69 · Sale (S): 2,525 @ $39.15 · Sale (S): 314 @ $38.70 · Option exercise (M): 4,503 (derivative) @ $34.70EDGAR
2026-09-224MIGNONE ROBERTO — DirectorSale (S): 367,600 @ $39.06EDGAR
2026-08-254Satchi-Fainaro Ronit — DirectorSale (S): 415 @ $37.25EDGAR
2026-08-254Weiss Amir — Chief Accounting OfficerSale (S): 6,945 @ $37.61 · Option exercise (M): 2,500 @ $19.61 · Sale (S): 2,500 @ $37.63 · Option exercise (M): 2,500 (derivative) @ $19.16EDGAR
2026-08-194Lippman Evan — EVP, Business DevelopmentSale (S): 18,600 @ $36.57EDGAR
2026-08-104Zaks Tal Zvi — DirectorSale (S): 17 @ $34.87EDGAR
2026-08-054Jover Placid — See "Remarks"Option exercise (M): 12,827 · Sale (S): 12,827 @ $34.88 · Option exercise (M): 12,827 (derivative) @ $0EDGAR
2026-08-054Hughes Eric A — See "Remarks"Option exercise (M): 52,744 · Sale (S): 25,578 @ $34.88 · Option exercise (M): 52,744 (derivative) @ $0EDGAR
2026-06-224Shields Matthew — EVP, Global OperationsSale (S): 9,989 @ $32.19EDGAR
2026-06-164Kalif Eliyahu Sharon — EVP, Chief Financial OfficerSale (S): 106,563 @ $34.10EDGAR
2026-06-084Lichtenstein Chen — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Satchi-Fainaro Ronit — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Elstein Amir — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Zaks Tal Zvi — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Nisen Perry — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Francis Richard D — President and CEOOption exercise (M): 13,043 · Sale (S): 6,153 @ $34.35 · Option exercise (M): 13,043 (derivative) @ $0EDGAR
2026-06-084Crane Rosemary A — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084MIGNONE ROBERTO — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084BARER SOL J — DirectorOption exercise (M): 21,739 · Option exercise (M): 21,739 (derivative) @ $0EDGAR
2026-06-084LIEBERMAN GERALD M — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-044Shields Matthew — EVP, Global OperationsOption exercise (M): 16,195 · Sale (S): 16,195 @ $32.87 · Option exercise (M): 16,195 (derivative) @ $0EDGAR
2026-06-014Lichtenstein Chen — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Satchi-Fainaro Ronit — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Elstein Amir — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Zaks Tal Zvi — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Nisen Perry — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Crane Rosemary A — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014MIGNONE ROBERTO — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014BARER SOL J — DirectorGrant/award (A): 10,863 (derivative) @ $0EDGAR
2026-06-014LIEBERMAN GERALD M — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-05-184Lippman Evan — EVP, Business DevelopmentOption exercise (M): 11,841 · Sale (S): 5,746 @ $35.58 · Option exercise (M): 74,008 · Sale (S): 35,912 @ $35.58 · Option exercise (M): 11,841 (derivative) @ $0 · Option exercise (M): 74,008 (derivative) @ $0EDGAR
2026-05-184Kalif Eliyahu Sharon — EVP, Chief Financial OfficerSale (S): 153,251 @ $35.61EDGAR
2026-05-074Weiss Amir — Chief Accounting OfficerSale (S): 10,679 @ $36EDGAR
2026-05-074Daniell Richard — EVP, Europe CommercialSale (S): 30,000 @ $35.40EDGAR
2026-05-044Fox Christine — EVP, U.S. CommercialSale (S): 21,258 @ $35.31EDGAR
2026-05-044Sabag Mark — See "Remarks"Sale (S): 144,180 @ $34.99EDGAR
2026-03-194Sabag Mark — See "Remarks"Sale (S): 62,102 @ $30.14EDGAR
2026-03-094Sabag Mark — See "Remarks"Option exercise (M): 15,723 · Option exercise (M): 15,723 (derivative) @ $0EDGAR
2026-03-094Francis Richard D — President and CEOOption exercise (M): 42,452 · Sale (S): 20,025 @ $31.67 · Option exercise (M): 42,452 (derivative) @ $0EDGAR

Recent 8-K events — TEVA PHARMACEUTICAL INDUSTRIES LTD

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-09-168-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other EventsEDGAR
2026-09-118-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-038-K3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-298-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-288-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TEVA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs